They had an average age at T2D diagnosis of 53.0 (standard deviation 11.8) years, were 57% female, were 49% non-Hispanic White, 62% were with obesity (BMI 30), had an average of 13.3 (8.2) years of EHR follow-up, and an average Quan-weighted Charlson Comorbidity Index (CCI) score of 2.8 (2.6) (Table 1)
Vision changes GLP-1s can affect the vision in several ways, including worsening vision in some cases due to rapid blood sugar correction or insufficient blood flow to the optic nerve
What can be done in the interim for the tens of millions of Americans with CVD related to obesity or overweight
Resistance training is essential for individuals both during and after use of GLP-1s to facilitate weight loss, as it can increase muscle mass, which in turn increases metabolic rate
As of this update, three Phase 3 programs have reported results
Therefore, GLP-1 in human blood is mainly secreted through the intestine